Trial
NCT04899921
Troriluzole or Placebo Plus Ipi Plus Nivo in Mel Brain Mets
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Dana-Farber Cancer Institute
Collaborators
Biohaven Pharmaceuticals, Inc.
Condition
Melanoma
Intervention
Ipilimumab
Why stopped
Due to poor enrollment
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-03-26